WeSearch

Dexcom RCT suggests CGM benefits for broad diabetes population

Mario Aguilar· ·1 min read · 0 reactions · 0 comments · 40 views
Dexcom RCT suggests CGM benefits for broad diabetes population

In this edition of STAT Health Tech: Dexcom's CGM trial, udpates from Apple's annual developers' conference, and wearables.

About this source

STAT News files mainly under health. We currently carry 208 of its stories.

All STAT News coverage →
Original article
STAT · Mario Aguilar
Read full at STAT →
Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from STAT

STAT+: Up and down the ladder: The latest comings and goings
STAT+: Up and down the ladder: The latest comings and goings
STAT5 views
 There are already more U.S. measles cases this year than in all of 2025
There are already more U.S. measles cases this year than in all of 2025
STAT4 views
 FDA advisory panel narrowly rejects compounding of one peptide, backs two others
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
STAT5 views
 Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
Opinion: I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
STAT4 views
 White House offers its science blueprint: More AI, less life sciences
White House offers its science blueprint: More AI, less life sciences
STAT4 views
 Opinion: The U.S. pharmaceutical supply chain problem is not about China
Opinion: The U.S. pharmaceutical supply chain problem is not about China
STAT10 views